Here is a current overview of best yielding stocks that have their ex-dividend date on the next trading day. If your broker settles your trade today, you will receive the next dividend. A full list of all stocks with ex-dividend date can be found here: Ex-Dividend Stocks March 19, 2012. In total, 10 stocks and preferred shares go ex-dividend of which 5 yielding above 3 percent. The average yield amounts to 4.44 percent.
Dividend Income orientated Blog. Ideas and Thoughts about Stocks, Dividends and Growth Opportunities.
Showing posts with label NDZ. Show all posts
Showing posts with label NDZ. Show all posts
The Best Yielding Healthcare Dividend Stocks With Fastest Earnings Growth
Healthcare Stocks With The Best Dividend Yield And Fastest Earnings Per Share Growth, Researched by Dividend Yield - Stock, Capital, Investment. Growth is a wonderful instrument for wealth building. I screened the healthcare sector by stocks with the highest earnings per share growth for the upcoming five years (at least 5 percent yearly). In addition, the company should pay today more than three percent in dividends. 10 stocks fulfilled my criteria of which six yielding above 4 percent. Nine stocks have a buy recommendation and one a strong buy rating.
15 Healthcare Dividend Stocks With Buy Or Better Recommendation
Healthcare Dividend Shares With Buy And Stong Buy Rating researched by Dividend Yield - Stock, Capital, Investment. Here is a current overview of stocks from the healthcare sector with a minimum dividend yield of 3 percent that have an actual buy or better rating outstanding. The recommendations are made by analysts and brokerage firms and measured on a scale between one and five. I listed all healthcare dividend stocks with a rating above 3 (buy or better). Exactly 15 companies fulfilled these criteria of which 8 have a strong buy rating and 7 a buy recommendation.
Here are the 3 top dividend stocks sorted by yield:
Psychemedics (NASDAQ: PMD) has a market capitalization of $47.64 million. The company employs 91 people, generates revenues of $20.11 million and has a net income of $2.61 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $4.70 million. Because of these figures, the EBITDA margin is 23.36 percent (operating margin 21.95 percent and the net profit margin finally 13.00 percent).
The total debt representing 0.00 percent of the company’s assets and the total debt in relation to the equity amounts to 0.00 percent. Due to the financial situation, a return on equity of 27.45 percent was realized. Twelve trailing months earnings per share reached a value of $0.66. Last fiscal year, the company paid $0.48 in form of dividends to shareholders.
Here are the price ratios of the company: The P/E ratio is 13.76, Price/Sales 2.37 and Price/Book ratio 4.87. Dividend Yield: 5.27 percent. The beta ratio is 0.84.
 |
| Long-Term Stock History Chart Of Psychemedics Corp. (Click to enlarge) |
 |
| Long-Term History of Dividends from Psychemedics Corp. (NASDAQ: PMD) (Click to enlarge) |
 |
| Long-Term Dividend Yield History of Psychemedics Corp. (NASDAQ: PMD) (Click to enlarge) |
GlaxoSmithKline (NYSE: GSK) has a market capitalization of $115.53 billion. The company employs 96,461 people, generates revenues of $44,106.82 million and has a net income of $2,878.62 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $8,494.51 million. Because of these figures, the EBITDA margin is 19.26 percent (operating margin 13.32 percent and the net profit margin finally 6.53 percent).
The total debt representing 35.76 percent of the company’s assets and the total debt in relation to the equity amounts to 169.91 percent. Due to the financial situation, a return on equity of 17.30 percent was realized. Twelve trailing months earnings per share reached a value of $2.02. Last fiscal year, the company paid $2.02 in form of dividends to shareholders.
Here are the price ratios of the company: The P/E ratio is 22.61, Price/Sales 2.60 and Price/Book ratio 8.41. Dividend Yield: 4.83 percent. The beta ratio is 0.63.
 |
| Long-Term Stock History Chart Of GlaxoSmithKline plc (ADR) (Click to enlarge) |
 |
| Long-Term History of Dividends from GlaxoSmithKline plc (ADR) (NYSE: GSK) (Click to enlarge) |
 |
| Long-Term Dividend Yield History of GlaxoSmithKline plc (ADR) (NYSE: GSK) (Click to enlarge) |
Sanofi SA (NYSE: SNY) has a market capitalization of $98.09 billion. The company employs 101,575 people, generates revenues of $41,469.25 million and has a net income of $5,640.13 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $13,867.96 million. Because of these figures, the EBITDA margin is 33.44 percent (operating margin 18.59 percent and the net profit margin finally 13.60 percent).
The total debt representing 9.69 percent of the company’s assets and the total debt in relation to the equity amounts to 15.56 percent. Due to the financial situation, a return on equity of 10.78 percent was realized. Twelve trailing months earnings per share reached a value of $2.29. Last fiscal year, the company paid $1.62 in form of dividends to shareholders.
Here are the price ratios of the company: The P/E ratio is 15.93, Price/Sales 2.38 and Price/Book ratio 1.39. Dividend Yield: 4.83 percent. The beta ratio is 0.89.
 |
| Long-Term Stock History Chart Of Sanofi SA (ADR) (Click to enlarge) |
 |
| Long-Term History of Dividends from Sanofi SA (ADR) (NYSE: SNY) (Click to enlarge) |
 |
| Long-Term Dividend Yield History of Sanofi SA (ADR) (NYSE: SNY) (Click to enlarge) |
Here is the full table with some fundamentals (TTM):
 |
| 15 Healthcare Dividend Stocks With Buy Or Better Recommendation (Click to enlarge) |
Take a closer look at the full table. The average price to earnings ratio (P/E ratio) amounts to 17.45 while the forward price to earnings ratio is 12.11. The dividend yield has a value of 3.99 percent. Price to book ratio is 3.11 and price to sales ratio 2.28. The operating margin amounts to 18.50 percent.
Related stock ticker symbols:
PMD, SNY, GSK, NDZ, MRK, NVS, PFE, VIVO, AVCA, BMY, UTMD, JNJ, ABT, MSA, LNCR
Selected Articles:
I am long JNJ. I receive no compensation to write about these specific stocks, sector or theme. I don't plan to increase or decrease positions or obligations within the next 72 hours.
For the other stocks: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I receive no compensation to write about any specific stock, sector or theme.
Subscribe to:
Posts (Atom)